Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4402-4406, August 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, M.
Right arrow Articles by Sasazuki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, M.
Right arrow Articles by Sasazuki, T.

Loss of Constitutional Heterozygosity in Colorectal Tumors from Patients with Familial Polyposis Coli and Those with Nonpolyposis Colorectal Carcinoma1

Masayuki Sasaki, Mieko Okamoto, Chieko Sato, Kenji Sugio, Jun-ichi Soejima, Takeo Iwama, Tatsuro Ikeuchi, Akira Tonomura, Michiko Miyaki and Takehiko Sasazuki2

Department of Genetics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812, Japan [M. S., K. S., J. S. T. S.]; Department of Biochemistry, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113, Japan [M. O., C. S., M. M.]; The Research Center for Polyposis and Intestinal Disease, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo 113, Japan [T. Iw]; and Department of Cytogenetics, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo 113, Japan [T. Ik., A. T.]

Familial polyposis coli (FPC) is an autosomal dominant tumorigenic disorder, the major gene of which is mapped to chromosome 5q. We searched for a gene loss in colorectal tumors from FPC patients, as related to tumorigenesis by inactivation of tumor suppression genes, using restriction fragment length polymorphism analysis. The findings were compared with those in the case of nonpolyposis colorectal carcinomas (NPCC). We examined specimens from 39 FPC patients, including 21 adenocarcinomas and 49 adenomas, and 23 colorectal carcinomas from 22 NPCC patients. For this, we used 53 polymorphic DNA markers on all autosomes. Frequent loss of heterozygosity in colorectal carcinoma from FPC patients was observed on chromosomes 5 (24%), 14 (20%), 17 (31%), 18 (40%), and 22 (35%) and also on chromosomes 5 (32%), 14 (30%), 17 (27%), 18 (20%), and 22 (19%) in NPCC. Although loss of heterozygosity in adenoma from FPC patients was observed on nine chromosomes, the frequencies were less than 7%. As we fractionated tumors only macroscopically, actual frequencies of loss of heterozygosity are probably somewhat higher. However, these results do suggest that tumor suppression genes for colorectal carcinoma may locate on chromosomes 5, 14, 17, 18, and 22 and that they may play a critical role in carcinogenesis in both FPC and NPCC patients.

1 This work was supported in part by Grants-in-Aid for Cancer Research 60010032, 60015072, 61010033, 61015078, 62010031, and 62015059 from the Ministry of Education, Science, and Culture, Japan, and by a Grant-in-Aid from the Fukuoka Cancer Society.

2 To whom requests for reprints should be addressed.

Received 8/29/88. Revised 2/16/89. Accepted 4/13/89.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
F Al-Mulla, S AlFadhli, A H Al-Hakim, J J Going, and M S Bitar
Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.
J. Clin. Pathol., June 1, 2006; 59(6): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D Kamnasaran and D W Cox
Current status of human chromosome 14
J. Med. Genet., February 1, 2002; 39(2): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S Shirasawa, M Furuse, N Yokoyama, and T Sasazuki
Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
Science, April 2, 1993; 260(5104): 85 - 88.
[Abstract] [PDF]


Home page
ScienceHome page
L. Su, K. Kinzler, B Vogelstein, A. Preisinger, A. Moser, C Luongo, K. Gould, and W. Dove
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
Science, May 1, 1992; 256(5057): 668 - 670.
[Abstract] [PDF]


Home page
ScienceHome page
K. Kinzler, M. Nilbert, L. Su, B Vogelstein, T. Bryan, D. Levy, K. Smith, A. Preisinger, P Hedge, D McKechnie, et al.
Identification of FAP locus genes from chromosome 5q21
Science, August 9, 1991; 253(5020): 661 - 665.
[Abstract] [PDF]


Home page
ScienceHome page
I Nishisho, Y Nakamura, Y Miyoshi, Y Miki, H Ando, A Horii, K Koyama, J Utsunomiya, S Baba, and P Hedge
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
Science, August 9, 1991; 253(5020): 665 - 669.
[Abstract] [PDF]


Home page
ScienceHome page
K. Kinzler, M. Nilbert, B Vogelstein, T. Bryan, D. Levy, K. Smith, A. Preisinger, Hamilton SR, P Hedge, A Markham, et al.
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
Science, March 15, 1991; 251(4999): 1366 - 1370.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.